Home/Filings/4/0001437749-25-035310
4//SEC Filing

Gregoire Sylvie 4

Accession 0001437749-25-035310

CIK 0001053691other

Filed

Nov 16, 7:00 PM ET

Accepted

Nov 17, 9:02 AM ET

Size

9.2 KB

Accession

0001437749-25-035310

Insider Transaction Report

Form 4
Period: 2025-11-13
Gregoire Sylvie
Director10% Owner
Transactions
  • Purchase

    Common Stock

    2025-11-13$7.51/sh+4,447$33,3971,471,578 total
  • Purchase

    Common Stock

    2025-11-14$7.57/sh+1,707$12,9221,473,285 total
  • Purchase

    Common Stock

    2025-11-14$7.55/sh+1,693$12,7821,693 total(indirect: By Spouse)
Footnotes (4)
  • [F1]Shares purchased in open-market transactions.
  • [F2]Shares held jointly by the Reporting Person and his spouse, Dr. John Alam, M.D., the Issuer's President & Chief Executive Officer and a member of the Issuer's Board of Directors.
  • [F3]Includes 1,707 shares held by the Sylvie Gregoire Roth IRA. The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.44 to $7.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range.
  • [F4]Includes 1,693 shares held by the John J. Alam Roth IRA. The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.41 to $7.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range.

Issuer

CervoMed Inc.

CIK 0001053691

Entity typeother

Related Parties

1
  • filerCIK 0001335822

Filing Metadata

Form type
4
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 9:02 AM ET
Size
9.2 KB